Real World Data Solutions Powered by Population Health Intelligence

The French Healthcare database SNDS: Access, Analysis, and Study Design

Certara is the first, non-academic applicant to be granted access to the French SNDS database of over 65 million lives with anonymized data on socio-demographics, medical characteristics, ambulatory care, hospitalizations, diagnosis, drugs and procedures, mortality, and costs.

As key opinion leaders, Certara’s real world data specialists speak regularly at international industry events and have significant communication and publication records.

Generate evidence to quantify opportunity and justify access

Generate evidence to quantify opportunity and justify access

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the largest and potentially the most comprehensive healthcare data resource, covering ~65 million lives, more than 99% of the French population and about 10% of Europe.

Drawing on decades of experience in real-world studies and renowned expertise in SNDS, we offer solutions for every need: from niche needs identification, justifying access, differentiating value, quantifying an opportunity to demonstrating benefit/risk.

  • Quantify Opportunity: Unmet needs, treatment patterns, burden of illness, market sizing
  • Justify Access: Cost minimization, cost offsets, cost effectiveness and budget impact analysis
  • Measure Performance: Drug utilization studies, relative effectiveness, outcomes performance, PAES
  • Ensure Safety: Benefit/risk assessment, risk management, signal detection, PASS

Quantify outcomes with patient and population-based research

Certara’s research has been instrumental in demonstrating the benefit that products and health technologies provide to patients. Certara offers real world data solutions for every need and SNDS represents a substantial part of it. Our SNDS studies are trusted by leading innovators to identify treatment patterns and patient outcomes, unmet needs among niche patient groups to target drugs, as well as burden of illness and resource utilization in the real world.

Quantify outcomes with patient and population-based research
Unmatched quality in data and analysis

Unmatched quality in data and analysis

Certara experts pioneered the use of electronic health care databases (EHCD) and electronic Medical Records (EMR) for conducting pharmaco-epidemiology studies. Our unique services link observational studies to advanced modeling in access data platforms built for bridging-to-real life studies.

Many of the typical challenges associated with conducting research using claims data can be addressed with appropriate study design and analysis using SNDS. The SNDS coverage (almost all people living in France), its universal nature and its size allow to minimize biases, long follow-up time (~10 years) and make it suitable for studying small patient populations, which is helpful when doing research on rare diseases and drug-related adverse events.


沪公网安备 31010102007374 号

Powered by GlobalLink OneLink Software